Objectives: To investigate current evidence linking ischemic postconditioning (IPC) to cardioprotection in patients receiving primary percutaneous coronary intervention (PCI). Methods: We performed searches of PubMed, Embase, MEDLINE and Cochrane databases from January 1998 to May 2011 for identifying relevant studies comparing IPC with usual care in patients undergoing primary PCI. A meta-analysis of eligible studies was assessed by Review Manager 5.0. Results: Thirteen studies were eligible. Compared to the control, observed outcomes such as peak creatine kinase [weighted mean difference (WMD) –537.48, 95% confidence interval (CI) –779.32 to –295.65 IU/l], peak creatine kinase-myocardial band (WMD –61.11, 95% CI –76.56 to –45.66 U/l), complete ST-segment resolution (risk ratio 1.38, 95% CI 1.07 to 1.77), blush grade during reflow (WMD 0.64, 95% CI 0.49 to 0.78), corrected TIMI frame count, single-photon emission computed tomography determining infarct size, long-term left ventricular ejection fraction and short-term and long-term wall motion score indexes were improved in IPC group, with less occurrence of heart failure during the 3-month to 3.4-year follow-up. Conclusions: Though current evidence indicates that IPC provides potential cardioprotection to patients receiving primary PCI, larger adequately powered studies should be undertaken to confirm its advantages.

1.
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579–H588.
2.
Ma X, Zhang X, Li C, Luo M: Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Intervent Cardiol 2006;19:367–375.
3.
Dow J, Kloner RA: Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther 2007;12:153–163.
4.
Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M: Postconditioning the human heart. Circulation 2005;112:2143–2148.
5.
Laskey WK: Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005;65:361–367.
6.
Petitti DB: 2000. Statistical methods in meta-analysis; in: Metaanalysis, Decision Analysis, and Cost-Effectiveness Analysis, ed 2. New York, Oxford University Press, pp 94–118.
7.
Ma XJ, Zhang XH, Li CM, Luo M: Effect of postconditioning on coronary blood flow velocity and endothelial function in patients with acute myocardial infarction. Scand Cardiovasc J 2006;40:327–333.
8.
Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K: ‘Postconditioning’ the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 2007;102:274–278.
9.
Zhao WS, Xu L, Wang LF, Zhang L, Zhang ZY, Liu Y, Liu XL, Yang XC, Cui L, Zhang L: A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis 2009;14:1204–1211.
10.
Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J: Rationale and design of the POSTEM (Postconditioning in ST-Elevation Myocardial Infarction) study. Cardiology 2010;116:103–109.
11.
Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Rydén L, Pernow J: Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010;96:1710–1715.
12.
Ma XJ, Zhang XH, Luo M, Li CM, Shao JH: Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction. Natl Med J China 2007;87:114–117.
13.
Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Liu SH, Zhang L, Jia HM, Vinten-Johansen J, Zhao ZQ: Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007;19:424–430.
14.
Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, André-Fouët X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M: Long-term benefit of postconditioning. Circulation 2008;117:1037–1044.
15.
Laskey WK, Yoon S, Calzada N, Ricciardi MJ: Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 2008;72:212–220.
16.
Lønborg J, Holmvang L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Treiman M, Jensen JS, Engstrøm T: ST-segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. Am Heart J 2010;160:1085–1091.
17.
Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrøm T: Cardioprotective effects of ischemic postconditioning in patients treated with primary precutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovas Interv 2010;3:34–41.
18.
Xue F, Yang X, Zhang B, Zhao C, Song J, Jiang T, Jiang W: Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010;33:439–444.
19.
Lin X, Zhang ZY, Wang LF, Zhang L, Liu Y, Liu XL, Yang XC, Cui L, Zhang L: Attenuation of tumor necrosis factor-α elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J 2010;123:1833–1839.
20.
Garcia S, Henry TD, Wang YL, Chavez IJ, Pedersen WR, Lesser JR, Shroff GR, Moore L, Traverse JH: Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction. J Cardiovasc Transl Res 2011;4:92–98.
21.
Liu T, Mishra AK, Ding F: Protective effect of ischemic postconditioning on reperfusion injury in patients with ST-segment elevation acute myocardial infarction. Chin J Cardiol 2011;39:35–39.
22.
Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:2011–2030.
23.
Kloner RA, Jennings RB: Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part 2. Circulation 2001;104:3158–3167.
24.
Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes Obes Metab 2008;10:451–459.
25.
Piper HM, Meuter K, Schafer C: Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003;75:S644–S648.
26.
Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–1136.
27.
Mykytenko Kerendi F, Reeves JG, Kin H, Zatta AJ, Jiang R, Guyton RA, Vinten-Johansen J, Zhao ZQ: Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol 2007;102:90–100.
28.
Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M: Postconditioning inhibits mitochondrial permeability transition. Circulation 2005;111:194–197.
29.
Skyschally A, Gres P, Van Caster P, Schulz R, Heusch G: Postconditioning reduces infarct size after ischemia/reperfusion in pigs. J Molec Cell Cardiol 2007;42:S171–S189.
30.
Lim SY, Davidson SM, Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007;75:530–535.
31.
Tang XL, Sato H, Tiwari S, Dawn B, Bi Q, Li Q, Shirk G, Bolli R: Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol 2006;291:H2308–H2317.
32.
Zhao Z, Vinten-Johansen J: Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006;70:200–211.
33.
Vuuren DV, Lochner M: Ischaemic postconditioning: from bench to bedside. Cardiovasc J Afr 2008;19:311–320.
34.
Yetgin T, Manintveld OC, Duncker DJ, van der Giessen WJ: Postconditioning against ischaemia-reperfusion injury: ready for wide application in patients. Neth Heart J 2010;18:389–392.
35.
Hansen PR, Thibault H, Abdulla J: Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. Int J Cardiol 2010;144:22–25.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.